Pharmaceutical สาธารณะ
[search 0]
เพิ่มเติม

ดาวน์โหลดแอปเลย!

show episodes
 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
 
Loading …
show series
 
This article was originally published by Abdrhman Mahmoud Gamil in World Journal of Advanced Research and Reviews, 2020, 08(03), 337–349 under a Creative Commons Attribution Liscense 4.0. Abstract Procurement is…The post Pharmaceutical procurement practice aspects appeared first on DrugPatentWatch - Make Better Decisions.…
 
This article was originally published by Andreas Bender and Isidro Cortes-Ciriano in Drug Discovery Today under a Creative Commons license. Although artificial intelligence (AI) has had a profound impact on…The post Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not t…
 
This article was originally published by Sajna T. in Management Insight, 16(1):38-40 under a creative commons license. Abstract Business enterprises are an important organ of society. The impact of a…The post Indian Pharma—Some Challenges and Acceptances appeared first on DrugPatentWatch - Make Better Decisions.…
 
Mark Schultz and Jaci McDole recently used DrugPatentWatch to complete a report on recent trends in the latest editions of the world health organization essential medicines list. Some of their key…The post Essential Medicines and Patents appeared first on DrugPatentWatch - Make Better Decisions.โดย DrugPatentWatch
 
PREVEN EMERGENCY CONTRACEPTIVE KIT (ethinyl estradiol; levonorgestrel) Teva branded pharmPatent: 6,156,742Expiration: Dec 5, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…The post Drug Patent Expirations for the Week of November 29, 2020 appeared first on DrugPatentWatch - Make B…
 
Annual Drug Patent Expirations for ENTEREG Entereg is a drug marketed by Cubist Pharms and is included in one NDA. It is available from one supplier. There are four patents…The post New patent expiration for Cubist Pharms drug ENTEREG appeared first on DrugPatentWatch - Make Better Decisions.โดย DrugPatentWatch
 
Less than a week away from the greatest playoffs battle of all time between the two expansion sides of 2020. Who's going to emerge victorious, the media darling, superstar-full Miami or the hard-working, MLS experienced Nashville?โดย Pharmaceutical Soccer
 
We prefer simple flat-rate unrestricted subscriptions — we’ll work on your terms, and with your favorite subscription contract template, to find a solution that fits. If your colleagues would like to…The post Thinking of signing your company up for DrugPatentWatch? appeared first on DrugPatentWatch - Make Better Decisions.…
 
Here is a copy of the talk I gave at the recent Marcusevans 13th Portfolio Management and Pipeline Optimization for Generics. I cover: How to find and evaluate generic entry…The post Finding and Evaluating Generic Drug Market Entry Opportunities appeared first on DrugPatentWatch - Make Better Decisions.…
 
This article not subject to U.S. Copyright. Published 2019 by the American Chemical Society. Noel T. Southall Abstract We report our experience working with the US Food and Drug Administration…The post Freedom of Information Act Access to an Investigational New Drug Application appeared first on DrugPatentWatch - Make Better Decisions.…
 
I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th Portfolio Management & Pipeline Optimization for Generics on September 30th.…The post Finding and Evaluating Generic Market Entry Opportunities appeared first on DrugPatentWatch - Make Better Decisions.…
 
This is a guest post by Shamil Gizatullin, Gowling WLG (International) Inc. shamil.gizatullin@gowlingwlg.com Although it has become harder to obtain patent-term extensions for drugs, pesticides or agricultural chemicals, a careful…The post Getting the most out of pharmaceutical patent-term extensions in Russia appeared first on DrugPatentWatch - Ma…
 
Don’t wait until the end of the year to start looking for alternatives to your existing business intelligence providers. DrugPatentWatch can help you replace or supplement your current solutions with:…The post Switching to DrugPatentWatch appeared first on DrugPatentWatch - Make Better Decisions.โดย DrugPatentWatch
 
Using data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at Bentley University published a paper investigating the involvement of government…The post Government as the First Investor in Biopharmaceutical Innovation appeared first on DrugPatentWatch - Make Better Decisions.…
 
In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means fewer generic entrants and less opportunities for consumers to enjoy…The post Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs appeared first on DrugPatentWatch - Make Better Decisions.…
 
Loading …

คู่มืออ้างอิงด่วน

Google login Twitter login Classic login